Theracryf Plc (AIM: TCF)
Health Care · Biotechnology · GB
£0.00
+2.94% today · -16.7% 1Y
Theracryf Plc (AIM: TCF) operates in the Biotechnology industry within the Health Care sector. The company is valued at $6.38M.
Over the last twelve months the share price has lost 16.7%, trading between 0.00 and 0.00.
Tweenvest scores Theracryf Plc across four factors: quality 35/100, value 65/100. Its strongest factor is value.
TCF price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $6.38M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 1.36
- 52-week high
- £0.00
- 52-week low
- £0.00
- Avg volume (3M)
- —
- Shares outstanding
- 2.73B
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AcouSort AB (publ)OM: ACOU | $6.54M | Skr3.06 | +2.00% |
| Curative Biotechnology, Inc.OTCPK: CUBT | $6.50M | $0.91 | -4.27% |
| Subgen AI AB (publ)OM: SUBGEN | $6.44M | Skr0.03 | +7.33% |
| XTL Biopharmaceuticals Ltd.TASE: XTLB | $6.41M | ₪0.02 | -6.25% |
| Moleculin Biotech, Inc.NasdaqCM: MBRX | $6.33M | $6.50 | +10.36% |
| Alzamend Neuro, Inc.NasdaqCM: ALZN | $6.27M | $1.30 | -2.99% |
| Coegin Pharma ABNGM: COEGIN | $6.26M | Skr2.17 | -10.33% |
| COSCIENS Biopharma Inc.TSX: CSCI | $6.11M | CA$8.62 | +0.23% |
Figures last refreshed Oct 18, 2026.